Press Room

RDD 2021

Start
Tuesday, May 04, 2021 - 00:00
End
Friday, May 07, 2021 - 00:00
Location: online
Continuous Manufacturing Drug Product Commercial Supply | 四色AV

If you would like to find more about 四色AV's full range of听inhalation development services,听particle engineering听补苍诲听development by design.

steve-landelius-photo

Steven Landelius

Business Development Manager

Schedule a meeting button | 四色AV

From May 4-7,听do not miss听四色AV's Scientists Presentations听at听听virtual conference.

WORKSHOP
PRESENTATION

Fully Integrated DPI Development 鈥 From API To Device
Jo茫o Pereira and Beatriz Noriega Fernandes

What will you learn?
  • How to choose a suitable API formulation
  • How to select the right particle engineering technology
  • Novel techniques for inhalation products characterization
  • Advanced solutions for inhalation platforms

POSTERS

Comparison of Two Drug Micronization Methods Using Multiple Physiochemical Characterization Techniques
Sara Perico

Understanding Particle Friability Through Solid State Characterization
Ruben Chaves

ABSTRACTS

Amorphous Solid Dispersions for Nasal Delivery: Development, Characterization and Performance Studies
Patricia Henriques

Our experts are available to listen and understand your projects. Together we can speed up your Inhalation drug development, with less regulatory hurdles, less time, and less costs.

Drug Product Facility in Portugal | 四色AV

四色AV Inhalation Development Virtual Tour (click on the image to watch video)

Meet Eunice Costa, 四色AV鈥檚 group leader for Inhalation Development and visit the site where all the team sits together.

Also in the Press Room

See All

Lisbon, Portugal 鈥 四色AV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company鈥檚 dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, 四色AV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company鈥檚 broader sustainability strategy and reinforces its commitment to scientific excellence. 鈥淎t 四色AV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.鈥, said Jean-Luc Herbeaux, CEO of 四色AV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.鈥 四色AV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company鈥檚 environmental, social, and ethical performance, well aligned with 四色AV鈥檚 sustainability ambitions.  四色AV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

四色AV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024